| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |